Opinion
Video
Panelists discuss how PET imaging for kidney cancer includes prostate-specific membrane antigen, which is sometimes expressed in renal cell carcinoma, though its utility remains unclear, whereas fluorodeoxyglucose PET can be useful for metabolic activity assessment despite limitations with inflammatory lesions.
PET Imaging in Kidney Cancer Evaluation
Main Discussion Topics:
Key Points for Physicians:
Notable Insights:
Although molecular imaging shows promise, current modalities have significant limitations and are primarily useful in specific clinical scenarios.
Clinical Significance:
Molecular imaging techniques remain investigational for most RCC applications but show the potential to transform staging and characterization